Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 15.18% is 46% below its 5-year average of 28.24%, near the low end of its 5-year range (15.18%–77.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.41% below its 12-month average of 21.50%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.18%.
DEBT TO ASSETS RATIO
15.18%
DEBT TO ASSETS RATIO AVG TTM
21.50%
DEBT TO ASSETS RATIO AVG 3Y
27.66%
DEBT TO ASSETS RATIO AVG 5Y
28.24%
DEBT TO ASSETS RATIO AVG 10Y
33.31%
DEBT TO ASSETS RATIO AVG 15Y
37.24%
DEBT TO ASSETS RATIO AVG 20Y
49.11%
CURRENT VS TTM AVG
-29.41%
CURRENT VS 3Y AVG
-45.12%
CURRENT VS 5Y AVG
-46.24%
CURRENT VS 10Y AVG
-54.43%
CURRENT VS 15Y AVG
-59.24%
CURRENT VS 20Y AVG
-69.09%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 602 covered companies
CURRENT VS SECTOR MEDIAN
+15080.04%
vs the sector median at left
INVO Fertility, Inc.
Market Cap
$1.45M
Debt to Assets Ratio
15.18%
TTM Avg
21.50%
3Y Avg
27.66%
5Y Avg
28.24%
Market Cap
$1.45M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.38M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.17M
Debt to Assets Ratio
0.47%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INVO Fertility, Inc. (IVF) | $1.45M | 15.18% | 21.50% | 27.66% | 28.24% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.45M | 0.02% | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.46M | 0.06% | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | 0.38% | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | 0.01% | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.37M | 0.04% | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.32M | 0.00% | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.21M | 0.56% | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.17M | 0.47% | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | 0.10% | N/A | N/A | N/A |
Debt/Assets
15.2%
Debt/Equity
0.24
Current Ratio
0.71
Interest Coverage
-4.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 15.18% |
| 2026-03-31 | 16.16% |
| 2025-12-31 | 16.81% |
| 2025-09-30 | 22.48% |
| 2025-06-30 | 36.88% |
| 2025-03-31 | 27.84% |
| 2024-12-31 | 21.30% |
| 2024-09-30 | 31.35% |
| 2024-06-30 | 29.82% |
| 2024-03-31 | 34.83% |
| 2023-12-31 | 34.05% |
| 2023-09-30 | 45.21% |
| 2023-06-30 | 77.34% |
| 2023-03-31 | 47.90% |
| 2022-12-31 | 64.92% |
| 2022-09-30 | 41.85% |
| 2022-06-30 | 31.35% |
| 2022-03-31 | 24.29% |
| 2021-12-31 | 20.29% |
| 2021-09-30 | 21.80% |
| 2021-06-30 | 17.14% |
| 2021-03-31 | 4.11% |
| 2020-12-31 | 7.08% |
| 2020-09-30 | 50.44% |
| 2020-06-30 | 47.29% |
| 2020-03-31 | 52.46% |
| 2019-12-31 | 25.48% |
| 2019-09-30 | 16.06% |
| 2019-06-30 | 11.81% |
| 2019-03-31 | 6.98% |
| 2018-12-31 | 50.89% |
| 2018-09-30 | 43.01% |
| 2018-06-30 | 32.46% |
| 2018-03-31 | 111.36% |
| 2017-12-31 | 128.60% |
| 2017-09-30 | 170.94% |
| 2017-06-30 | 188.47% |
| 2017-03-31 | 176.15% |
| 2016-12-31 | 123.19% |
| 2016-09-30 | 90.52% |
| 2016-06-30 | 48.55% |
| 2016-03-31 | 40.21% |
| 2015-12-31 | 38.10% |
| 2011-12-31 | 381.06% |
| 2011-09-30 | 96.95% |
| 2011-06-30 | 331.09% |
| 2011-03-31 | 276.45% |
| 2010-12-31 | 255.58% |
| 2010-09-30 | 272.87% |
| 2010-06-30 | 192.85% |
| 2010-03-31 | 121.73% |
| 2009-12-31 | 72.46% |
| 2009-09-30 | 48.02% |
| 2009-06-30 | 87.21% |
| 2009-03-31 | 73.01% |
| 2008-12-31 | 47.01% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 61.99% |
| 2008-03-31 | 39.07% |
| 2007-12-31 | 0.67% |
